Short interest in Enlivex Therapeutics Ltd (NASDAQ:ENLV) decreased during the last reporting period, falling from 140.81K to 117.18K. This put 0.6% of the company's publicly available shares short.

Short interest for Enlivex Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Enlivex Therapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 122.61K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.